Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
KUNLUN ENERGY
00135
CN Stock MarketDetailed Quotes
Tecon Biology Co.Ltd (002100)
- 7.18
- -0.13-1.78%
Market Closed May 20 15:00 CST
9.80BMarket Cap-97.03P/E (TTM)
7.29High7.14Low165.59KlotVolume7.29Open7.31Prev Close119.08MTurnover1.21%Turnover Ratio46.62P/E (Static)1.37BShares8.4652wk High1.43P/B9.80BFloat Cap6.0252wk Low8.04Limit Up1.37BShs Float18.80Historical High6.58Limit Down2.05%Range %-0.54Historical Low0.22Dividend TTM7.19Avg Price90.68KlotAsk3.06%Div Yield TTM100Lot Size72.09KlotBid
Tecon Biology Co.Ltd (002100) Balance Sheet
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -13.03%2.83B | -32.92%2.08B | 3.51%3.78B | 3.87%2.97B | 21.28%3.25B | 9.93%3.1B | -5.06%3.65B | -25.54%2.86B | -31.02%2.68B | -15.00%2.82B |
| Transactional financial assets | 2,652.15%426.28M | 6,235.57%349.97M | 1,140.39%130.8M | 6,705.69%35.56M | 3,177.18%15.49M | 1,067.66%5.52M | --10.55M | -99.48%522.51K | --472.63K | -99.93%473.08K |
| Notes receivable and accounts receivable | -0.41%628.11M | -15.72%450.05M | -13.14%650.78M | 4.81%642.98M | -11.45%630.68M | 23.97%533.99M | -8.40%749.25M | -16.17%613.5M | -3.53%712.26M | 7.93%430.75M |
| -Notes receivable | -86.94%7.57M | -90.31%6.26M | -41.66%43.11M | 359.39%61.89M | 117.54%57.94M | 571.06%64.57M | 348.98%73.9M | -32.03%13.47M | 67.52%26.64M | -11.60%9.62M |
| -Accounts receivable | 8.35%620.54M | -5.46%443.79M | -10.02%607.67M | -3.16%581.09M | -16.47%572.73M | 11.47%469.43M | -15.74%675.36M | -15.73%600.02M | -5.09%685.63M | 8.48%421.13M |
| Other receivables (including interest and dividends) | -17.52%248.43M | -36.13%170.25M | -19.15%300.05M | -6.73%264.66M | 17.66%301.21M | 2.86%266.56M | 5.62%371.11M | -5.95%283.77M | -16.98%256M | -13.60%259.14M |
| -Other receivable | ---- | ---- | ---- | -6.73%264.66M | ---- | 2.86%266.56M | ---- | -5.95%283.77M | ---- | -13.60%259.14M |
| Advance payment | -4.78%628.37M | -12.80%729.58M | 9.51%944.49M | 73.70%549.27M | 36.20%659.93M | 116.45%836.72M | 131.55%862.5M | -20.41%316.22M | -27.30%484.52M | -65.96%386.57M |
| Inventories | 9.25%5.35B | 21.16%5.57B | 2.40%3.07B | -12.48%3.78B | 3.21%4.89B | 0.87%4.59B | -7.40%3B | -15.59%4.32B | -30.13%4.74B | -24.63%4.55B |
| Receivable financing | ---- | 102.38%170K | 24.35%14.03M | 491.06%13.55M | --3.96M | -99.38%84K | --11.28M | --2.29M | ---- | 397.94%13.53M |
| Other current assets | 9.96%523.11M | 14.21%547.35M | 5.14%435.69M | 1.30%489.49M | -0.88%475.72M | 0.70%479.24M | 24.20%414.37M | 2.55%483.24M | -19.20%479.93M | -11.04%475.88M |
| Total current assets | 5.32%10.79B | 1.04%9.95B | 3.19%9.41B | -1.36%8.78B | 9.48%10.24B | 9.90%9.85B | 1.71%9.12B | -18.97%8.9B | -27.97%9.36B | -27.71%8.96B |
| Non Current assets | ||||||||||
| Long-term equity investment | -37.98%15.94M | -50.38%16.52M | -29.65%23.61M | -19.28%27.31M | -31.16%25.7M | -7.80%33.29M | -13.59%33.56M | -12.16%33.83M | 74.83%37.34M | -65.76%36.11M |
| Fixed assets | ---- | ---- | ---- | 7.35%5.66B | ---- | 10.43%5.89B | ---- | 3.84%5.28B | ---- | 4.05%5.33B |
| Constru in process | ---- | ---- | ---- | -65.84%287.88M | ---- | -71.39%233.09M | ---- | 0.69%842.66M | ---- | 91.63%814.7M |
| Productive biological assets | 12.06%310.9M | 21.26%330.36M | 7.11%300.72M | -4.54%279.41M | -6.13%277.45M | -15.07%272.43M | -22.75%280.75M | -19.38%292.7M | -22.07%295.55M | -10.65%320.76M |
| Intangible assets | -2.83%362.34M | -3.55%363.78M | -6.88%362.83M | -4.52%368.29M | -3.09%372.88M | 4.52%377.17M | 15.56%389.63M | 13.12%385.71M | 40.79%384.78M | 34.44%360.84M |
| Development expenditure | -89.25%772.46K | -89.51%750K | 83.22%5.79M | 672.18%5.79M | 15.65%7.18M | 1.96%7.15M | -65.10%3.16M | -89.57%750K | -52.15%6.21M | -9.52%7.01M |
| Goodwill | 0.00%165.82M | 0.00%165.82M | -7.09%165.82M | -7.09%165.82M | -7.09%165.82M | -7.09%165.82M | -17.02%178.48M | -17.02%178.48M | -47.96%178.48M | 702.42%178.48M |
| Long deferred expense | 15.19%27.2M | 46.15%28.25M | 14.52%21.6M | 6.40%22.18M | 0.70%23.61M | -19.58%19.33M | -13.80%18.86M | -3.74%20.84M | 12.31%23.45M | 4.18%24.04M |
| Deferred tax assets | 6.13%115.6M | 13.23%112.25M | 29.81%119.76M | 54.30%115.2M | 46.97%108.92M | 37.35%99.14M | 101.40%92.26M | 172.55%74.66M | 72.12%74.12M | 82.53%72.18M |
| Usufruct assets | -11.32%476.01M | -12.35%507.73M | -18.93%493.08M | -19.08%510.89M | -17.69%536.76M | -7.12%579.26M | 5.35%608.22M | 13.07%631.36M | 16.12%652.15M | 14.91%623.65M |
| Other non current assets | -69.20%9.23M | 2.46%39.17M | -31.32%20.08M | 8.48%19.49M | 11,010.49%29.97M | 97.69%38.22M | -30.29%29.23M | -57.13%17.97M | -99.20%269.78K | -58.77%19.34M |
| Total non current assets | -3.98%7.25B | -3.55%7.44B | -5.07%7.41B | -3.72%7.47B | -3.27%7.55B | -0.98%7.71B | 1.98%7.81B | 2.96%7.75B | 5.76%7.81B | 11.84%7.79B |
| Total assets | 1.37%18.04B | -0.98%17.39B | -0.62%16.82B | -2.46%16.24B | 3.68%17.8B | 4.84%17.56B | 1.84%16.92B | -10.05%16.65B | -15.75%17.17B | -13.48%16.75B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -8.43%2.86B | -3.70%3.11B | -12.30%2.23B | -23.77%2.06B | -1.86%3.12B | -2.59%3.23B | 129.68%2.54B | 1.60%2.7B | -16.66%3.18B | 3.26%3.32B |
| Notes payable and accounts payable | 46.70%714.83M | -1.68%601.58M | 5.93%648.6M | -11.64%512.93M | -25.44%487.28M | -12.23%611.86M | -4.16%612.29M | 6.27%580.5M | 25.42%653.57M | 14.07%697.12M |
| -Notes payable | 5,036.98%198.42M | 873.07%103.06M | -54.97%6.69M | -78.72%5.06M | -81.68%3.86M | 99.93%10.59M | 76.47%14.85M | 463.86%23.79M | --21.08M | --5.3M |
| -Accounts payable | 6.83%516.42M | -17.09%498.51M | 7.45%641.92M | -8.77%507.87M | -23.57%483.41M | -13.09%601.27M | -5.23%597.44M | 2.71%556.71M | 21.37%632.49M | 13.21%691.82M |
| Contract liabilities | 16.95%1.04B | 20.61%802.88M | -27.41%533.8M | 41.98%708M | 85.45%892.79M | 51.21%665.66M | 112.15%735.34M | -32.28%498.67M | -1.51%481.41M | -6.82%440.23M |
| Advance receipts | 582.55%1.17M | 250.19%1.25M | --115.84K | --218.34K | --171.84K | 636.10%357.08K | ---- | ---- | ---- | -41.79%48.51K |
| Salaries payable | -21.09%196.89M | -32.14%172.98M | 0.48%234.81M | 5.34%231.91M | -6.77%249.51M | -14.33%254.91M | -4.07%233.7M | -11.65%220.16M | -14.11%267.63M | -5.01%297.56M |
| Taxs payable | 12.82%31.54M | -19.45%19.96M | -30.86%23.45M | 222.56%29.36M | -31.32%27.96M | -22.02%24.78M | 18.11%33.92M | -54.90%9.1M | 66.33%40.72M | 29.09%31.78M |
| Other payable (including interest and dividends) | 13.20%732.38M | -12.53%611.05M | -11.66%680.19M | -3.06%672.49M | -6.68%646.98M | -4.48%698.55M | 0.10%769.96M | -8.81%693.75M | -29.92%693.29M | -0.38%731.35M |
| -Other payable | ---- | ---- | ---- | -3.06%672.49M | ---- | -4.48%698.55M | ---- | -2.63%693.75M | ---- | 0.02%731.35M |
| Non current liabilities due within one year | -20.51%922.21M | 23.11%1.07B | -7.36%1.01B | -22.59%1.24B | -31.98%1.16B | -41.82%865.9M | -52.08%1.09B | 4.99%1.6B | 57.44%1.71B | 104.82%1.49B |
| Other current liabilities | -17.38%92.29M | -24.38%105.31M | -47.69%78.74M | 44.62%92.89M | 69.23%111.71M | 71.26%139.26M | 148.26%150.54M | -19.90%64.23M | -15.17%66.01M | -23.21%81.31M |
| Total current liabilities | -1.45%6.6B | -0.00%6.49B | -11.82%5.43B | -12.90%5.54B | -5.56%6.7B | -8.36%6.49B | 12.73%6.16B | -3.16%6.36B | -3.00%7.1B | 14.16%7.09B |
| Current liabilities | ||||||||||
| Long term loan | 28.59%2.55B | -8.84%1.88B | 31.78%2.16B | 10.10%1.63B | 27.18%1.98B | 67.90%2.06B | -7.55%1.64B | -41.99%1.48B | -45.79%1.56B | -60.89%1.23B |
| Estimate liabilities | -98.53%94.47K | -98.53%94.47K | --94.47K | --6.42M | --6.42M | --6.42M | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | 0.64%17.68M | 2.62%18.08M | -1.63%17.53M | 1.80%17.53M | -0.60%17.57M | -2.83%17.62M | 7.65%17.82M | 2,310.20%17.22M | 2,374.31%17.68M | 1,150.15%18.13M |
| Long term deferred income | 6.12%150.43M | 5.79%152.94M | 3.49%146.28M | -2.87%140.37M | -1.93%141.76M | 0.90%144.58M | 29.47%141.35M | 48.88%144.51M | 60.50%144.54M | 63.74%143.29M |
| Lease liabilities | -6.74%278.09M | -2.82%313.04M | -39.52%290.38M | -39.22%300.6M | -27.17%298.17M | -11.24%322.12M | 5.83%480.09M | 32.60%494.54M | 27.32%409.42M | 19.96%362.93M |
| Total non current liabilities | 22.46%3B | -7.39%2.36B | 14.75%2.61B | -1.95%2.1B | 14.84%2.45B | 45.63%2.55B | -3.14%2.28B | -29.32%2.14B | -35.21%2.13B | -50.36%1.75B |
| Total liabilities | 4.95%9.6B | -2.08%8.85B | -4.65%8.05B | -10.15%7.64B | -0.85%9.15B | 2.33%9.04B | 7.95%8.44B | -11.40%8.5B | -13.00%9.23B | -9.20%8.84B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 0.76%1.37B | 0.77%1.37B | 0.79%1.37B | 0.81%1.37B |
| Capital reserve funds | 0.07%3.95B | 0.07%3.95B | 0.02%3.94B | 0.00%3.94B | 0.00%3.94B | 0.00%3.94B | 0.70%3.94B | 0.75%3.94B | 0.15%3.94B | 2.60%3.94B |
| Surplus reserve funds | 0.00%466.77M | 0.00%466.77M | 0.00%466.77M | 0.00%466.77M | 0.00%466.77M | 0.00%466.77M | 6.31%466.77M | 6.31%466.77M | 6.31%466.77M | 6.31%466.77M |
| Retained profit | -30.06%933.44M | -7.56%1.1B | 16.63%1.3B | 48.63%1.22B | 110.02%1.33B | 104.07%1.19B | -22.38%1.11B | -44.74%823.8M | -72.26%635.46M | -74.39%581.39M |
| Other composite income | 1,368.83%144.63M | 24.67%63.65M | 70.55%93.79M | 150.49%25.76M | 667.52%9.85M | -0.11%51.06M | 1,117.36%54.99M | -54.34%10.28M | -115.39%-1.74M | 3,494.81%51.12M |
| Ordinary risk reserve funds | 0.00%3.85M | 0.00%3.85M | 0.00%3.85M | 0.00%3.85M | 0.00%3.85M | 0.00%3.85M | 0.00%3.85M | 0.00%3.85M | 0.00%3.85M | 0.00%3.85M |
| Shareholders equity without minority interests | -3.70%6.86B | -1.06%6.94B | 3.23%7.17B | 6.29%7.03B | 11.09%7.12B | 9.44%7.02B | -2.91%6.95B | -8.51%6.61B | -20.25%6.41B | -19.01%6.41B |
| Minority interests | 3.63%1.58B | 6.09%1.6B | 4.07%1.6B | 2.37%1.58B | -0.03%1.53B | -0.02%1.5B | -6.59%1.53B | -8.89%1.54B | -11.69%1.53B | -12.28%1.5B |
| Total shareholder equity | -2.41%8.44B | 0.20%8.54B | 3.39%8.77B | 5.55%8.6B | 8.95%8.65B | 7.64%8.52B | -3.60%8.48B | -8.58%8.15B | -18.73%7.94B | -17.81%7.91B |
| Total liabilityies and equity | 1.37%18.04B | -0.98%17.39B | -0.62%16.82B | -2.46%16.24B | 3.68%17.8B | 4.84%17.56B | 1.84%16.92B | -10.05%16.65B | -15.75%17.17B | -13.48%16.75B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Huaxing Certified Public Accountants (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants (Special General Partnership) | -- | -- | -- | Sigma Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S.
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm